HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Saadettin Kılıçkap Selected Research
Saadettin Kılıçkap Research Topics
Disease
9
Neoplasms (Cancer)
07/2023 - 01/2020
5
Neoplasm Metastasis (Metastasis)
01/2023 - 06/2019
4
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 01/2022
3
Adenocarcinoma
08/2023 - 10/2021
3
Carcinoma (Carcinomatosis)
03/2022 - 08/2021
2
Breast Neoplasms (Breast Cancer)
02/2024 - 12/2022
2
Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2023 - 01/2020
2
Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 06/2019
2
Inflammation (Inflammations)
12/2022 - 10/2022
2
Renal Cell Carcinoma (Grawitz Tumor)
12/2022 - 12/2021
2
Kidney Neoplasms (Kidney Cancer)
12/2022 - 12/2021
2
Stomach Neoplasms (Stomach Cancer)
06/2022 - 10/2021
2
Urinary Bladder Neoplasms (Bladder Cancer)
03/2022 - 08/2021
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2023
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2022
1
Male Breast Neoplasms (Male Breast Cancer)
12/2022
1
Lung Neoplasms (Lung Cancer)
08/2022
1
Disease Progression
06/2022
1
Prostatic Neoplasms (Prostate Cancer)
05/2021
1
Cholangiocarcinoma
02/2021
1
medullary Thyroid cancer
09/2020
1
Pulmonary Fibrosis (Fibrosing Alveolitis)
07/2020
1
Fibrosis (Cirrhosis)
07/2020
1
COVID-19
01/2020
Drug/Important Bio-Agent (IBA)
4
atezolizumab
IBA
12/2022 - 08/2021
3
Platinum
IBA
03/2022 - 08/2021
2
Hormones (Hormone)
IBA
02/2024 - 12/2022
2
ErbB Receptors (EGF Receptor)
IBA
02/2024 - 12/2022
2
Crizotinib
IBA
07/2023 - 08/2022
2
alectinib
IBA
07/2023 - 01/2022
2
Nivolumab
IBA
12/2022 - 12/2021
2
Trastuzumab (Herceptin)
FDA Link
06/2022 - 10/2021
2
Hemoglobins (Hemoglobin)
IBA
03/2022 - 08/2021
1
palbociclib
IBA
02/2024
1
ribociclib
IBA
02/2024
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
02/2024
1
Anaplastic Lymphoma Kinase
IBA
11/2023
1
Capecitabine (Xeloda)
FDA Link
10/2023
1
Temozolomide (Temodar)
FDA Link
Generic
10/2023
1
Biomarkers (Surrogate Marker)
IBA
12/2022
1
Proton Pump Inhibitors
IBA
12/2022
1
Cyclin-Dependent Kinase 4
IBA
12/2022
1
regorafenib
IBA
12/2022
1
Phosphotransferases (Kinase)
IBA
10/2022
1
entrectinib
IBA
08/2022
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
08/2022
1
Cisplatin (Platino)
FDA Link
Generic
06/2022
1
Tyrosine Kinase Inhibitors
IBA
01/2022
1
taxane
IBA
10/2021
1
Creatinine
IBA
08/2021
1
gallium Ga 68 dotatate
IBA
09/2020
1
Everolimus
FDA Link
07/2020
1
Sirolimus (Rapamycin)
FDA Link
07/2020
1
OMS 2017
IBA
01/2020
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
01/2020
1
Yttrium-90
IBA
06/2019
Therapy/Procedure
8
Drug Therapy (Chemotherapy)
12/2022 - 07/2020
7
Therapeutics
01/2023 - 07/2020
2
Immunotherapy
03/2022 - 08/2021
2
Microspheres (Microsphere)
02/2021 - 06/2019
1
Metastasectomy
08/2023
1
Radiotherapy
07/2020